Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy

Interleukin-2: Inception, Impact, and Implications

1988 • 2,166 citations

Suppressor Effector Function of CD4+CD25+ Immunoregulatory T Cells Is Antigen Nonspecific

2000 • 1,282 citations

Manual of Clinical Laboratory Immunology

1992 • 1,243 citations

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1999 • 815 citations

Antigen-independent activation of naive and memory resting T cells by a cytokine combination.

1994 • 541 citations

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

1997 • 527 citations

CD8 naive T cell counts decrease progressively in HIV-infected adults.

1995 • 495 citations

Increases in CD4 T Lymphocytes with Intermittent Courses of Interleukin-2 in Patients with Human Immunodeficiency Virus Infection — A Preliminary Study

1995 • 430 citations

Controlled Trial of Interleukin-2 Infusions in Patients Infected with the Human Immunodeficiency Virus

1996 • 406 citations

Human T-lymphocyte growth factor: regulation of growth and function of T lymphocytes

1981 • 289 citations

Identification of a human recent thymic emigrant phenotype

2000 • 243 citations

Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor.

1997 • 192 citations

Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity.

1996 • 168 citations

Subcutaneous Administration of Interleukin‐2 in Human Immunodeficiency Virus Type 1—Infected Persons

1997 • 164 citations

Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy

2000 • 95 citations

Outpatient Continuous Intravenous Interleukin‐2 or Subcutaneous, Polyethylene Glycol‐Modified Interleukin‐2 in Human Immunodeficiency Virus‐Infected Patients: A Randomized, Controlled, Multicenter Study

1998 • 92 citations

Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects.

1997 • 82 citations

Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies.

1998 • 59 citations

Effects of Intermittent Interleukin‐2 Therapy on Plasma and Tissue Human Immunodeficiency Virus Levels and Quasi‐Species Expression

2000 • 30 citations

Immunotherapy of HIV-Infected Patients with Intermittent Interleukin-2: Effects of Cycle Frequency and Cycle Duration on Degree of CD4+ T-Lymphocyte Expansion

2001 • 20 citations

Pharmacokinetic modeling of recombinant interleukin-2 in patients with human immunodeficiency virus infection

1998 • 17 citations